These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 6497088)
1. Characteristics of protective activity of Mycoplasma hyopneumoniae vaccine. Ross RF; Zimmermann-Erickson BJ; Young TF Am J Vet Res; 1984 Oct; 45(10):1899-905. PubMed ID: 6497088 [TBL] [Abstract][Full Text] [Related]
2. Aerosol vaccination of pigs against Mycoplasma hyopneumoniae infection. Murphy D; Van Alstine WG; Clark LK; Albregts S; Knox K Am J Vet Res; 1993 Nov; 54(11):1874-80. PubMed ID: 8291766 [TBL] [Abstract][Full Text] [Related]
3. Protective effect of vaccination with culture supernate of M. hyopneumoniae against experimental infection in pigs. Okada M; Asai T; Ono M; Sakano T; Sato S J Vet Med B Infect Dis Vet Public Health; 2000 Sep; 47(7):527-33. PubMed ID: 11048434 [TBL] [Abstract][Full Text] [Related]
4. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine. Okamba FR; Arella M; Music N; Jia JJ; Gottschalk M; Gagnon CA Vaccine; 2010 Jul; 28(30):4802-9. PubMed ID: 20472025 [TBL] [Abstract][Full Text] [Related]
5. Mycoplasmal pneumonia in pigs in Croatia: first evaluation of a vaccine in fattening pigs. Bilić V; Lipej Z; Valpotić I; Habrun B; Humski A; Njari B Acta Vet Hung; 1996; 44(3):287-93. PubMed ID: 9055454 [TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro comparisons of spray-drying and solvent- evaporation preparation of microencapsulated Mycoplasma hyopneumoniae for use as an orally administered vaccine for pigs. Lin JH; Pan MJ; Liao CW; Weng CN Am J Vet Res; 2002 Aug; 63(8):1118-23. PubMed ID: 12171164 [TBL] [Abstract][Full Text] [Related]
7. Mycoplasma hyopneumoniae: interaction with other agents in pigs, and evaluation of immunogens. Ciprián A; Cruz TA; de la Garza M Arch Med Res; 1994; 25(2):235-9. PubMed ID: 7919820 [TBL] [Abstract][Full Text] [Related]
8. Oral vaccination against mycoplasmal pneumonia of swine using a live Erysipelothrix rhusiopathiae vaccine strain as a vector. Ogawa Y; Oishi E; Muneta Y; Sano A; Hikono H; Shibahara T; Yagi Y; Shimoji Y Vaccine; 2009 Jul; 27(33):4543-50. PubMed ID: 19433128 [TBL] [Abstract][Full Text] [Related]
9. Reduced lung lesions in pigs challenged 25 weeks after the administration of a single dose of Mycoplasma hyopneumoniae vaccine at approximately 1 week of age. Reynolds SC; St Aubin LB; Sabbadini LG; Kula J; Vogelaar J; Runnels P; Peters AR Vet J; 2009 Sep; 181(3):312-20. PubMed ID: 18554964 [TBL] [Abstract][Full Text] [Related]
10. Improvement of complement fixation test antigen for the diagnosis of Mycoplasma hyopneumoniae infection. Mori Y; Yoshida Y; Kuniyasu C; Hashimoto K Natl Inst Anim Health Q (Tokyo); 1983; 23(4):111-6. PubMed ID: 6240607 [TBL] [Abstract][Full Text] [Related]
11. Effect of age on susceptibility of pigs to Mycoplasma hyopneumoniae pneumonia. Piffer IA; Ross RF Am J Vet Res; 1984 Mar; 45(3):478-81. PubMed ID: 6711977 [TBL] [Abstract][Full Text] [Related]
12. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant. Djordjevic SP; Eamens GJ; Romalis LF; Nicholls PJ; Taylor V; Chin J Aust Vet J; 1997 Jul; 75(7):504-11. PubMed ID: 9258425 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibodies to Mycoplasma hyopneumoniae in Iowa swine. Young TF; Ross RF; Drisko J Am J Vet Res; 1983 Oct; 44(10):1946-8. PubMed ID: 6638651 [TBL] [Abstract][Full Text] [Related]
14. Effect of vaccination on the potentiation of porcine reproductive and respiratory syndrome virus (PRRSV)-induced pneumonia by Mycoplasma hyopneumoniae. Thacker EL; Thacker BJ; Young TF; Halbur PG Vaccine; 2000 Jan; 18(13):1244-52. PubMed ID: 10649626 [TBL] [Abstract][Full Text] [Related]
15. The Mycoplasma hyopneumoniae plasma membrane as a vaccine against porcine enzootic pneumonia. Kobisch M; Quillien L; Tillon JP; Wróblewski H Ann Inst Pasteur Immunol; 1987; 138(5):693-705. PubMed ID: 3440060 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs. Woolley LK; Fell SA; Gonsalves JR; Raymond BB; Collins D; Kuit TA; Walker MJ; Djordjevic SP; Eamens GJ; Jenkins C Vaccine; 2014 Jul; 32(34):4333-41. PubMed ID: 24930717 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2. Kim D; Kim CH; Han K; Seo HW; Oh Y; Park C; Kang I; Chae C Vaccine; 2011 Apr; 29(17):3206-12. PubMed ID: 21354247 [TBL] [Abstract][Full Text] [Related]
18. A field trial to evaluate a Mycoplasma hyopneumoniae vaccine: effects on lung lesions and growth rates in swine. Dohoo IR; Montgomery ME Can Vet J; 1996 May; 37(5):299-302. PubMed ID: 8705975 [TBL] [Abstract][Full Text] [Related]
19. Isolation of Mycoplasma hyopneumoniae from lesions in experimentally infected pigs. Etheridge JR; Cottew GS; Lloyd LC Aust Vet J; 1979 Aug; 55(8):356-9. PubMed ID: 533486 [TBL] [Abstract][Full Text] [Related]
20. Effect of vaccination of pigs against experimental infection with high and low virulence Mycoplasma hyopneumoniae strains. Villarreal I; Maes D; Vranckx K; Calus D; Pasmans F; Haesebrouck F Vaccine; 2011 Feb; 29(9):1731-5. PubMed ID: 21237277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]